CO5580790A2 - Composicion farmaceutica de fondaparinux sodio para el tratamiento de acs - Google Patents

Composicion farmaceutica de fondaparinux sodio para el tratamiento de acs

Info

Publication number
CO5580790A2
CO5580790A2 CO04030711A CO04030711A CO5580790A2 CO 5580790 A2 CO5580790 A2 CO 5580790A2 CO 04030711 A CO04030711 A CO 04030711A CO 04030711 A CO04030711 A CO 04030711A CO 5580790 A2 CO5580790 A2 CO 5580790A2
Authority
CO
Colombia
Prior art keywords
acs
treatment
pharmaceutical composition
sulfo
phondaparinux
Prior art date
Application number
CO04030711A
Other languages
English (en)
Inventor
Anthonie Lensing
Arnold Wilhelmus
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8181220&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO5580790(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of CO5580790A2 publication Critical patent/CO5580790A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

1.- Una composición farmacéutica que comprende el pentasacárido metil O-(2-desoxi-2-sulfoamino-6- O-sulfo-a-D-glucopiranosilo)-(1?4)-O-(ácido ß-D-glucopiranosil urónico)-(1?4)-O-(2-desoxi-2-sulfoamino-3,6-di-O-sulfo- a-D-glucopiranosilo)-(1?4)-O-(ácido 2-O-sulfo-a-L-idinopiranosil urónico)-(1?4)-2-desoxi-2-sulfoamino-6-O-sulfo-a-D-glucopiranosido o una sal farmacéuticamente aceptable del mismo en una cantidad de 2.5 mg para el tratamiento de los Síndromes Coronarios Agudos (ACS).
CO04030711A 2001-11-13 2004-03-31 Composicion farmaceutica de fondaparinux sodio para el tratamiento de acs CO5580790A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01204323 2001-11-13

Publications (1)

Publication Number Publication Date
CO5580790A2 true CO5580790A2 (es) 2005-11-30

Family

ID=8181220

Family Applications (1)

Application Number Title Priority Date Filing Date
CO04030711A CO5580790A2 (es) 2001-11-13 2004-03-31 Composicion farmaceutica de fondaparinux sodio para el tratamiento de acs

Country Status (37)

Country Link
US (1) US20040248848A1 (es)
EP (1) EP1446131B1 (es)
JP (1) JP4523276B2 (es)
KR (1) KR20050044318A (es)
CN (1) CN1602197A (es)
AP (1) AP1820A (es)
AR (1) AR037291A1 (es)
AT (1) ATE361753T1 (es)
AU (1) AU2002351915B2 (es)
BR (1) BR0212915A (es)
CA (1) CA2465776A1 (es)
CO (1) CO5580790A2 (es)
CY (1) CY1106765T1 (es)
DE (1) DE60220084T2 (es)
DK (1) DK1446131T3 (es)
EA (1) EA007325B1 (es)
EC (1) ECSP045041A (es)
ES (1) ES2287343T3 (es)
GE (1) GEP20074097B (es)
HK (1) HK1070561A1 (es)
HR (1) HRP20040303B1 (es)
HU (1) HU228959B1 (es)
IL (2) IL161114A0 (es)
IS (1) IS2484B (es)
MA (1) MA27071A1 (es)
ME (2) MEP1108A (es)
MX (1) MXPA04003045A (es)
NO (1) NO20041320L (es)
NZ (1) NZ552129A (es)
PE (1) PE20030740A1 (es)
PL (1) PL206008B1 (es)
PT (1) PT1446131E (es)
RS (1) RS50906B (es)
SI (1) SI1446131T1 (es)
UA (1) UA80399C2 (es)
WO (1) WO2003041722A1 (es)
ZA (1) ZA200402464B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090075910A1 (en) * 2007-09-13 2009-03-19 Protia, Llc Deuterium-enriched fondaparinux
EP3973958A3 (en) * 2015-03-20 2022-06-22 Aarhus Universitet Inhibitors of pcsk9 for treatment of lipoprotein metabolism disorders
US10688249B2 (en) * 2015-06-11 2020-06-23 Virchow Biotech Pvt. Ltd. Multiple dose pharmaceutical compositions containing heparin and/or heparin-like compounds and devices and methods for delivering the same
CN107595769A (zh) * 2017-10-23 2018-01-19 上海博悦生物科技有限公司 一种磺达肝癸钠注射液组合物的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2662442A1 (fr) * 1990-05-23 1991-11-29 Midy Spa Trifluoromethylphenyltetrahydropyridines n-substituees procede pour leur preparation, intermediaires du procede et compositions pharmaceutiques les contenant.
CA2199642C (en) * 1997-03-10 2001-05-08 Roger Cariou Compositions containing an association of aspirin and an anti-xa oligosaccharide and use of an anti-xa oligosaccharide optionally in combination with aspirin
FR2764511B1 (fr) * 1997-06-13 2000-09-08 Sanofi Sa Compositions pour le traitement et la prevention de la thrombose arterielle et utilisation d'un inhibiteur du facteur xa seul et/ou en combinaison avec un antiagregant plaquettaire
EP1551852A4 (en) * 2002-04-25 2007-03-21 Momenta Pharmaceuticals Inc METHOD AND PRODUCTS FOR MUCOSAL DELIVERY

Also Published As

Publication number Publication date
AP1820A (en) 2008-01-11
ECSP045041A (es) 2004-04-28
JP2005509007A (ja) 2005-04-07
HU228959B1 (en) 2013-07-29
ZA200402464B (en) 2005-06-29
AR037291A1 (es) 2004-11-03
EA007325B1 (ru) 2006-08-25
MA27071A1 (fr) 2004-12-20
EP1446131B1 (en) 2007-05-09
EP1446131A1 (en) 2004-08-18
MXPA04003045A (es) 2005-06-20
DK1446131T3 (da) 2007-09-10
ME00229B (me) 2011-10-10
UA80399C2 (en) 2007-09-25
RS50906B (sr) 2010-08-31
WO2003041722A1 (en) 2003-05-22
PL369027A1 (en) 2005-04-18
ATE361753T1 (de) 2007-06-15
IS2484B (is) 2008-12-15
ES2287343T3 (es) 2007-12-16
PE20030740A1 (es) 2003-08-28
CA2465776A1 (en) 2003-05-22
IS7199A (is) 2004-03-29
PT1446131E (pt) 2007-08-07
KR20050044318A (ko) 2005-05-12
HUP0401462A2 (en) 2006-02-28
CN1602197A (zh) 2005-03-30
PL206008B1 (pl) 2010-06-30
GEP20074097B (en) 2007-05-10
DE60220084D1 (de) 2007-06-21
BR0212915A (pt) 2004-10-13
AP2004003014A0 (en) 2004-06-30
SI1446131T1 (sl) 2007-10-31
IL161114A0 (en) 2004-08-31
HK1070561A1 (en) 2005-06-24
CY1106765T1 (el) 2012-05-23
MEP1108A (en) 2011-02-10
IL161114A (en) 2010-11-30
NO20041320L (no) 2004-06-14
HRP20040303A2 (en) 2004-10-31
JP4523276B2 (ja) 2010-08-11
EA200400382A1 (ru) 2004-10-28
DE60220084T2 (de) 2008-01-10
US20040248848A1 (en) 2004-12-09
HRP20040303B1 (en) 2012-02-29
NZ552129A (en) 2008-04-30
RS26704A (en) 2007-02-05
AU2002351915B2 (en) 2007-11-29
HUP0401462A3 (en) 2006-04-28

Similar Documents

Publication Publication Date Title
CO5160320A1 (es) Metodos y composiciones para la prevencion de tolerancia a medicamentos das.
UY26635A1 (es) Métodos sinérgicos y composiciones para el tratamiento del cáncer
AR037490A1 (es) Composiciones farmaceuticas solidas, proceso para su preparacion, kit para el tratamiento de la obesidad y uso de dichas composiciones en la elaboracion de medicamentos
PA8453201A1 (es) Formulaciones farmaceuticas que contienen voriconazol
MX9202407A (es) Composicion farmaceutica que contiene un compuesto de alilamina como el agente activo y proceso para su preparacion.
NO20100302L (no) Sammensetninger som inneholder organiske forbindelser
IT1245761B (it) Formulazioni farmaceutiche contenenti glicosaminoglicani assorbibili per via orale.
ES2081531T3 (es) Composiciones farmaceuticas que contienen rifaximina para el tratamiento de infecciones vaginales.
EA199801086A1 (ru) Неводные медицинские средства для очистки толстой кишки
PE20020307A1 (es) Forma de dosificacion de farmaco activada por hidrogel
ES2145557T3 (es) Composiciones de ablandamiento del agua y composiciones detergentes.
AR033688A1 (es) Composicion parenteral reconstituible
AR054806A1 (es) Formulaciones de estrogenos conjugados y bazedoxifeno
ATE255909T1 (de) Konservierungssystem für topisch verabreichbare pharmazeutische zusammensetzungen
PT1073467E (pt) Formulacoes de co-solvente que compreendem um composo de vitamina d.
ES2104845T3 (es) Composiciones lipofilas de sales de antibioticos oligosacaridos.
CO5190674A1 (es) Tratamiento de desordenes neuroticos desordenes neuroticos
IS2258B (is) Setin tríasóló-pýridasín afleiða, lyfjasamsetningar gerðar úr henni
CO5540294A2 (es) Una combinacion de un derivado de rapamicina y un agente alquilante seleccionado de ciclofosfamida y carmustina y composiciones que las contienen
CO5580790A2 (es) Composicion farmaceutica de fondaparinux sodio para el tratamiento de acs
CO5550418A2 (es) Formulaciones antihistaminicas para formas de dosificacion de capsula blanda
ES2150404T3 (es) Composiciones farmaceuticas de tizoxanida y nitozoxanida.
ITMI912745A1 (it) Derivati 5h-benzodiazepinici, composizioni farmaceutiche che li contengono e procedimento per la loro preparazione.
AR002191A1 (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion, procedimiento para su preparacion
ITMI910846A1 (it) Derivati di flavoni, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono

Legal Events

Date Code Title Description
FC Application refused